-
1421
Rapid microcystin-LR detection using antibody-based electrochemical biosensors with a simplified calibration curve approach
Published 2024-12-01“…Abstract Harmful algal blooms (HABs) can release cyanotoxins such as microcystins (MCs), especially, microcystin-leucine-arginine (MC-LR) which is one of the commonest and most toxic, into our water bodies and can lead to several acute or chronic diseases such as liver diseases and respiratory irritation in humans. There is an increasing need for rapid and simple detection of MC-LR in water bodies for early warning of HABs. …”
Get full text
Article -
1422
Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study
Published 2025-01-01Get full text
Article -
1423
Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells
Published 2022-01-01Get full text
Article -
1424
-
1425
Bile microbiocenosis in cats suffering from acute cholangiohepatitis
Published 2020-09-01“…Cholangiohepatitis, one of the most common liver diseases in cats, is often fatal. The focus of the study was the bile of cats, suffering from acute cholangiohepatitis. …”
Get full text
Article -
1426
Targeting ASK1 by CS17919 alleviates kidney‐ and liver‐related diseases in murine models
Published 2025-01-01“…Conclusions CS17919 showed cell protective, anti‐inflammatory, and antifibrotic effects in vitro and in vivo, suggesting its therapeutic potential for metabolic‐related kidney and liver diseases.…”
Get full text
Article -
1427
TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
Published 2025-02-01“…Objectives: Dysregulation of lipid homeostasis pathway causes many liver diseases, including hepatic steatosis. One of the primary factors contributing to lipid accumulation is fatty acid uptake by the liver. …”
Get full text
Article -
1428
The Effect of FOXA3 Overexpression on Hepatocyte Differentiation and Liver Regeneration in a Fah cKO Mouse ModelSummary
Published 2025-01-01“…Partial hepatectomy and liver transplantation are effective treatments for liver diseases. This study investigated the effect of FOXA3 on cell differentiation in HepaRG cell lines under 2- and 3-dimensional culture conditions. …”
Get full text
Article -
1429
Rapid Detection of microRNA-122 in Serum and Finger Blood Using a Lateral Flow Nucleic Acid Biosensor
Published 2025-01-01“…An expanding body of research has demonstrated that miR-122 is a critical regulator in both the initiation and progression of a wide range of liver diseases. Traditional methods for detecting miR-122 mainly include Northern blotting and qRT-PCR, but they are technically complex and cumbersome, requiring expensive instruments and high technical requirements. …”
Get full text
Article -
1430
Insights into the Correlation between Toll-Like Receptor 2 Polymorphism and HBV-Related Disease Progression and Occurrence of Hepatocellular Carcinoma: A Case-Control Study in Egyp...
Published 2024-01-01“…Therefore, this study highlights the impact of TLR2 gene polymorphism on the progression of HBV-linked liver diseases (liver cirrhosis and HCC). Methods. In total, 170 chronic HBV patients and 50 healthy controls of comparable age and gender were included in this case-control study. …”
Get full text
Article -
1431
-
1432
STUDY OF THE EFFECT OF METHIONINE HYPERHOMOCYSTEINEMIA AND ITS CORRECTION WITH CHOLINE AND VITAMIN D ON THE CONDITION OF THE PERIODONTIUM, SMALL INTESTINE, AND LIVER OF RATS
Published 2024-10-01“…In recent years, there have been reports of a clinical relationship between periodontitis, intestinal and liver diseases of the human body, the so-called "oral-intestinal-hepatic axis", although the causal mechanism of such an "association" is still unclear. …”
Get full text
Article -
1433
Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance
Published 2025-01-01“…Background and objectiveQinggan Yipi Capsule (QgYp) is a hospital preparation that has been used for many years in the treatment of chronic liver diseases. However, the mechanism of QgYp in ameliorating hepatic fibrosis (HF) remains unclear. …”
Get full text
Article -
1434
Effects of oral Lcarnitine supplementation on liver enzymes in pediatric acute lymphoblastic leukemia patients in the maintenance phase of treatment: a randomized clinical trial st...
Published 2025-01-01“…BackgroundGiven that liver diseases and subsequent increases in liver enzymes are among the most frequent complications observed in leukemia patients treated with chemotherapeutic drugs, this study aimed to assess the impact of oral Lcarnitine supplementation on liver enzyme levels the maintenance phase of treatment for pediatric acute lymphoblastic leukemia (ALL) patients.MethodsIn this clinical trial, 100 pediatric patients aged >5 years were divided into two groups after obtaining informed consent. …”
Get full text
Article -
1435
Risk factors for fear of falling in stroke patients: a systematic review and meta-analysis
Published 2022-06-01Get full text
Article -
1436
A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE
Published 2018-01-01Get full text
Article -
1437
Neutrophils restricted contribution of CCRL2 genetic variants to COVID-19 severity
Published 2025-01-01Get full text
Article -
1438
-
1439
-
1440
Risk factors for the ineffectiveness of assisted reproductive technology programs after a woman’s illness with COVID-19
Published 2023-11-01“…A significant difference was also established in the frequency of liver diseases (21.9% vs. 6.3%, p<0.05) and gastrointestinal tract (23.4% vs. 12.5%, p<0.05). …”
Get full text
Article